Yinang Formulation Versus Placebo Granules as a Treatment for Chronic Kidney Disease Stages III–IV in Patients With Autosomal Dominant Polycystic Kidney Disease: Study Protocol for a Double-Blind Placebo-Controlled Randomized Clinical Trial

Trials - United Kingdom
doi 10.1186/s13063-019-3563-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Octreotide-Lar in Later-Stage Autosomal Dominant Polycystic Kidney Disease (ALADIN 2): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2019English

Rapamycin for Treatment of Type I Autosomal Dominant Polycystic Kidney Disease (RAPYD-study): A Randomized, Controlled Study

Nephrology Dialysis Transplantation
MedicineTransplantationNephrology
2012English

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Advances in Therapy
MedicinePharmacology
2019English

Orally Active Prostacyclin Analogue Beraprost Sodium in Patients With Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Dose Finding Trial

BMC Nephrology
Nephrology
2015English

Minocycline as Adjunctive Treatment for Treatment-Resistant Depression: Study Protocol for a Double Blind, Placebo-Controlled, Randomized Trial (MINDEP2)

BMC Psychiatry
PsychiatryMental Health
2020English

Peritoneal Dialysis for Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study

Journal of Zhejiang University: Science B
GeneticsPharmacologyMolecular BiologyBiochemistryVeterinaryMedicineToxicologyPharmaceutics
2016English

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Canadian Journal of Kidney Health and Disease
Nephrology
2017English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy